About Cellular Engineering Technologies
Cellular Engineering Technologies is a company based in Coralville (United States) founded in 2000 by Alan Moy. Cellular Engineering Technologies has raised $45 thousand across 3 funding rounds from investors including HHS. Cellular Engineering Technologies offers products and services including Human iPSC Reprogramming Kit, Human iPSC Growth Media Kit, Human Recombinant BDNF Protein, and Human Wharton’s Jelly-Derived Mesenchymal Stem Cells. Cellular Engineering Technologies operates in a competitive market with competitors including Multus, Metatissue, Nu-Tek Biosciences, Kohjin Bio and Sarvoshadhi Bio, among others.
- Total Equity Funding$45K (USD)
in 3 rounds
- Latest Funding Round$721.02K (USD), Grant
Aug 2020
- Investors
Products & Services of Cellular Engineering Technologies
Cellular Engineering Technologies offers a comprehensive portfolio of products and services, including Human iPSC Reprogramming Kit, Human iPSC Growth Media Kit, Human Recombinant BDNF Protein, and Human Wharton’s Jelly-Derived Mesenchymal Stem Cells.
Kit for efficient reprogramming of cells into iPSCs for research purposes
Media formulation to support iPSC expansion and maintenance
Protein for enhancing cell growth in research applications
Cells derived for use in disease modeling and therapy research
Funding Insights of Cellular Engineering Technologies
Cellular Engineering Technologies has successfully raised a total of $45K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $721.02 thousand completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $45,000
- Total Rounds 3
- Last Round Grant — $721,021
- First Round $15,000
(Jun 2011)
- Investors Count 1
All 3 funding rounds of Cellular Engineering Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2020 | $721,021 | Grant | – | – | |
| Feb 2014 | $30,000 | Series A | – | – | – |
| Jun 2011 | $15,000 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Cellular Engineering Technologies
Cellular Engineering Technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Cellular Engineering Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cellular Engineering Technologies
2 people are tracked at Cellular Engineering Technologies (2 in leadership).
| Name | Role | Group |
|---|---|---|
Alan Moy | Co-Founder | Leadership |
Marc J Centrella | CEO | Leadership |
Complete people profiles for Cellular Engineering Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cellular Engineering Technologies
3 dated milestones of Cellular Engineering Technologies across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Cellular Engineering Technologies is founded.
- Funding First funding round of $15K.
- Funding Latest funding round, Grant, of $721K.
Competitors of Cellular Engineering Technologies
Cellular Engineering Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Multus, Metatissue, Nu-Tek Biosciences, Kohjin Bio and Sarvoshadhi Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| multus.bio | 2019 | London, United Kingdom | $9.3M | 8 | Provider of lab-grown meat alternatives | |
| metatissue.com | 2018 | Ilhavo, Portugal | – | – | Provider of human protein-based products for cell culture, tissue engineering, and disease modeling applications | |
| nu-tekbiosciences.com | 2008 | Minnetonka, United States | – | – | Develops innovative animal-free peptones and cell culture media for pharmaceutical use. | |
| kohjin-bio.jp | 1981 | Sakado, Japan | – | – | Tissue culture media provided for regenerative medicine and immunotherapy research. | |
| sarvoshadhi.com | 2017 | Kolhapur, India | – | – | Customized cell culture media for biotechnology are developed. | |
| metaboliq.ca | 2022 | Canada | – | – | Developer of cell culture medium for pharmaceutical screening and personalized medicine | |
| onkologic.com | 2021 | Farmington, United States | $305,000 | – | NK cell culture media is developed for cancer cell therapies. | |
| alt-biotech.com | 2023 | Evry Courcouronnes, France | – | – | Delivers comprehensive cell-culture solutions for producing non-therapeutic recombinant proteins. |
Detailed competitors of Cellular Engineering Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cellular Engineering Technologies
The website of Cellular Engineering Technologies (cet.bio) receives about 1.8K visits a month.
- Monthly visits1.8K
▼ 43.9% vs previous month
Similar companies to Cellular Engineering Technologies
10 companies that operate in the same segment as Cellular Engineering Technologies (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cellular Engineering Technologies
Cellular Engineering Technologies was founded in 2000 and raised its 1st funding round 11 years after it was founded.
Cellular Engineering Technologies is headquartered in Coralville, United States. It is registered at Coralville, Iowa, United States.
Marc J Centrella is the current CEO of Cellular Engineering Technologies.
Cellular Engineering Technologies is a funded company, having raised a total of $45K across 3 funding rounds to date. The company's 1st funding round was a Seed of $15K, raised on Jun 2011.
Cellular Engineering Technologies was founded in 2000 and is based in Coralville, United States. Operations focus on the biotechnology sector, where induced pluripotent stem cells, media formulations, and growth factor proteins are provided. These resources support researchers and process development professionals in cell-based studies. Services aim to facilitate research acceleration without direct involvement in clinical applications.
Cellular Engineering Technologies's top competitors include Multus, Onkologic and Metatissue.
Cellular Engineering Technologies offers Human iPSC Reprogramming Kit, Human iPSC Growth Media Kit, Human Recombinant BDNF Protein, and Human Wharton’s Jelly-Derived Mesenchymal Stem Cells.
Cellular Engineering Technologies has 1 investor. Key investors include HHS.
Cellular Engineering Technologies operates through Cellular Engineering Technologies, Inc..